Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Aug 2022 – 20 Aug 2026, limited by Bandhan Midcap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Midcap Fund | Nifty Midcap 150 |
|---|---|---|
| 19 Aug 2022 | ₹100.00 | ₹100.00 |
| 19 Dec 2022 | ₹99.56 | ₹103.57 |
| 20 Apr 2023 | ₹98.09 | ₹100.47 |
| 20 Aug 2023 | ₹115.82 | ₹121.30 |
| 19 Dec 2023 | ₹134.18 | ₹143.89 |
| 19 Apr 2024 | ₹142.47 | ₹154.78 |
| 19 Aug 2024 | ₹174.52 | ₹182.47 |
| 19 Dec 2024 | ₹182.18 | ₹184.35 |
| 20 Apr 2025 | ₹154.15 | ₹166.08 |
| 20 Aug 2025 | ₹176.15 | ₹184.30 |
| 19 Dec 2025 | ₹174.04 | ₹189.26 |
| 20 Apr 2026 | ₹174.04 | ₹188.23 |
| 20 Aug 2026 | ₹193.58 | ₹199.88 |
| Metric | Bandhan · Regular NAV ₹19.38 Very High risk ★★★☆☆ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +9.89% | +8.71% | |
| +18.63% | +18.06% | |
| — | +16.16% | |
| — | +15.69% | |
| +17.94% | +16.93% | |
| +17.03% | — | |
| +20.05% | +19.07% | |
| — | +16.56% | |
| — | +16.43% | |
| Risk | ||
| 16.59% | 16.23% | |
| 0.73 | 0.74 | |
| 1.00 | 1.00 | |
| -23.32% | -37.39% | |
| Nifty Midcap 150 | — | |
| +0.84% | +0.94% | |
| 0.96 | 0.94 | |
| 98.7% | 96.2% | |
| 95.5% | 90.1% | |
| 2.13% | 2.04% | |
| ₹2,155Cr | ₹7,594Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 28% | 41% | |
| Harshal Joshi | — | |
| 19 Aug 2022 | — | |
| 85 | — | |
| 27.4% | — | |
| 3.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.